Developer docs
API playgroundTry for free, no card

Search company profiles

ODAIA

Full company profile

uuid0000eey

Namestring
ODAIA
Legal namestring
ODAIA Intelligence Inc.
Websiteurl
odaia.ai
Company typeenum
Private
Founded yearint
2018
Descriptiontext

ODAIA Intelligence Inc. is a Toronto-based, venture-backed AI software company founded in 2018 that builds MAPTUAL, a vertical AI platform purpose-built for pharmaceutical and biopharma commercial teams. The platform unifies data science, behavioral science, and AI across five proprietary engines — Value (HCP PowerScore), Curation (dynamic call lists), Insights (GenAI pre-call summaries), Sequencing (omnichannel orchestration), and Attribution (Rx-based campaign attribution) — to identify which healthcare professionals (HCPs) to engage, when, through which channel, and with what message. Underlying infrastructure is cloud-native and serverless on AWS (Lambda, Aurora, Fargate/Karpenter), with XGBoost, TensorFlow, a Parquet-based ML feature store, and bidirectional integrations into Veeva CRM (including a MyInsights tile) and Salesforce CRM, plus API connections to media and agency partners such as Publicis, CMI, Klick Health, DeepIntent, Telium, and Pulse Health.

ODAIA packages MAPTUAL into three primary product modules: ODAIA Field Intelligence for sales reps (with the ODAIA Field Coach add-on for sales managers), ODAIA Marketing Intelligence for marketing and brand teams, and the newly launched ODAIA Brand Strategy Studio for aligning brand planning with commercial execution. The company sells exclusively via direct enterprise SaaS subscriptions on quote-based, multi-year contracts, supplemented by implementation and integration services; pricing is not publicly disclosed and all engagement starts with a discovery call or demo. It reports 40+ pharma brands onboarded across customers including GSK, Novo Nordisk, Acadia Pharmaceuticals, Ardelyx, BeiGene, Daiichi Sankyo, and four of the top 15 global biopharmas.

ODAIA has raised roughly $43M in disclosed equity funding across pre-seed (Sep 2019), seed (Nov 2020), Series A (Feb 2022, $13.8M, Flint Capital lead), and a follow-on round (May 2023, $25M, Monograph Capital and Threshold co-lead), with secondary offices in Boston, MA and a remote-first operating model. Industry recognition includes being named a Sample Vendor in Gartner's 2023 Hype Cycle for Life Science Commercial Operations and the sole Major Contender and Star Performer in Everest Group's 2024 PEAK Matrix for Life Sciences Next-Generation Customer Engagement Platforms.

Short descriptiontext

ODAIA is a Toronto-based AI software company that builds MAPTUAL, a vertical AI platform for pharmaceutical and biopharma commercial teams, delivering predictive HCP targeting, GenAI pre-call insights, omnichannel campaign orchestration, and Rx-based attribution to sales reps, marketers, and brand leaders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical analytics platform, HCP engagement software, AI customer data platform, pharma commercial intelligence, omnichannel marketing analytics
Product category
Pharmaceutical Commercial Intelligence Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Enterprise SaaS subscriptions
TypeSubscription Recurring
Description

Recurring software subscriptions for ODAIA Field and ODAIA Marketing Intelligence, sold to biopharma commercial teams (sales, marketing, brand) on a SaaS basis. Configurable deployments with multi-week setup, integrated with existing CRMs and media partners.

odaia.ai
2Implementation, Integration & Onboarding Services
TypeProfessional Services
Description

Professional services for configuration, integration with agency/media partners, and TPAs (third-party data) setup to deploy MAPTUAL for new customer brands.

odaia.ai
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Quote-based enterprise SaaS — no public price list
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly disclosed; customers must request a discovery call for a tailored walkthrough. Multi-product platform with Field Intelligence, Marketing Intelligence, Field Coach, and Platform Overview offerings.

odaia.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1MAPTUAL
Description

ODAIA's cloud-based AI platform integrating data science, behavioral science, and AI for commercial pharma teams; the trademarked name is referenced alongside the ODAIA name in copyright notices and product descriptions.

odaia.ai
+4 more records
Core offering1 text field

ODAIA sells MAPTUAL, an AI-powered Commercial Intelligence Platform built specifically for pharmaceutical companies. The platform unifies prescribing data, engagement signals, CRM records, and physician attributes to deliver real-time HCP prioritization, dynamic call planning, individualized omnichannel campaign orchestration, and Rx-based attribution for pharma sales, marketing, brand, and commercial operations teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 40+ brands onboarded, $53B+ revenue supported, 7–14% average incremental Rx lift, +14% brand reach
+6 more records
Product overview1 text field

ODAIA's offering is a platform-plus-modules architecture centered on its cloud solution MAPTUAL. The MAPTUAL platform provides the shared AI foundation (Value, Curation, Insights, Sequencing, and Attribution engines) and ships to customers as three primary product modules: ODAIA Field Intelligence (for sales reps, including the ODAIA Field Coach add-on for sales managers), ODAIA Marketing Intelligence (for marketing and brand teams), and the newly launched ODAIA Brand Strategy Studio (for aligning brand planning with commercial execution). Solution layers (Targeting Intelligence, Engagement Intelligence, Omnichannel Marketing, and Opportunity Analysis) and a CRM-embedded ODAIA Insights view for Veeva extend the platform across the pharma commercial workflow.

Product and service6 records
1ODAIA Field Intelligence
CategoryHCP Engagement Software
Description

ML-driven SaaS product for pharma sales reps that uses patented ML models to compute HCP PowerScores, generate dynamic call lists, surface pre-call insights, and prioritize the right physicians for engagement. Integrates with Veeva CRM via MyInsights.

2ODAIA Marketing Intelligence
CategoryPharma Omnichannel Campaign Orchestration
Description

AI SaaS product for pharma marketing and brand teams that orchestrates individualized HCP campaigns by analyzing prescribing data, engagement signals, CRM records, and physician attributes in real time, with Rx-based attribution and bidirectional API integrations with Veeva, Salesforce, Publicis, CMI, Klick Health, DeepIntent, Telium, and Pulse Health.

3ODAIA Field Coach
CategorySales Manager Performance Analytics
Description

Performance intelligence add-on module for pharma sales managers that delivers real-time territory assessment, per-rep activity analysis against PowerScore-driven suggestions, personalized coaching insights, and continuous performance tracking.

4ODAIA Brand Strategy Studio
CategoryBrand Strategy Planning Software
Description

AI-native platform designed to align pharma sales, marketing, and analytics teams by automating strategic planning, simulating market impacts, and enabling continuous brand strategy refinement based on real-time data.

5MAPTUAL Platform
CategoryCore AI Platform
Description

The cloud-based AI platform that powers all ODAIA products, composed of five engines: Value Engine (HCP PowerScore), Curation Engine (Dynamic Call Lists), Insights Engine (GenAI pre-call insights), Sequencing Engine (omnichannel campaign orchestration), and Attribution Engine (Rx-based attribution).

6Opportunity Analysis
CategoryDiagnostic / Advisory Service
Description

One-time diagnostic analysis service that identifies overlooked or over-served HCPs, territories, and growth areas for a pharma commercial team, typically delivered as a precursor engagement before dynamic targeting deployment.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagship Technology / Gtm PartnershipTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

ODAIA and Pulse Health announced a technology partnership at the JP Morgan Healthcare Conference in San Francisco on January 14, 2026, combining their AI-powered marketing platforms to help pharmaceutical brands personalize HCP engagement. A joint customer deployed over 600 campaigns using the integrated solution, with ODAIA recommending 86% of HCPs in the target universe; the first month of activation yielded 10% HCP-to-Rx conversion and a 25% prescription volume increase among converters.

2Andrew Gunn (new senior hire)
Strategic tierLeadership Expansion; Not A Corporate PartnerTypeOthersAnnounced on2025-11-19
Description

ODAIA announced the addition of senior pharma and AI leaders Andrew Gunn and Jacqueline Markle to accelerate growth and industry adoption. Andrew Gunn is a senior leader (named hire), not a corporate alliance, and is captured here only for completeness given the source framing.

prnewswire.com
3Jacqueline Markle (new senior hire)
Strategic tierLeadership Expansion; Not A Corporate PartnerTypeOthersAnnounced on2025-11-19
Description

ODAIA announced the addition of senior pharma and AI leaders Andrew Gunn and Jacqueline Markle to accelerate growth and industry adoption. Jacqueline Markle is a senior leader (named hire), not a corporate alliance, and is captured here only for completeness given the source framing.

prnewswire.com
Strategic tierFlagship Crm IntegrationTypeTechnology or Integration
Description

ODAIA integrates with Veeva CRM (including Veeva MyInsights) via a GenAI solution that delivers real-time, predictive HCP insights inside the rep workflow. ODAIA Field's Veeva integration is showcased as a primary 'Seamless Integration with Your CRM' on the Field product page, and a Veeva CRM Integration Demo is one of three flagship demo videos.

Strategic tierCore Crm IntegrationTypeTechnology or Integration
Description

ODAIA connects with Salesforce CRM in addition to Veeva, with bidirectional API integrations used to activate HCP engagement sequences.

Strategic tierMajor Media/Agency PartnerTypeChannel Partner/ Reseller/ Distributor
Description

Publicis is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API, helping pharma customers activate HCP campaigns through Publicis' media assets.

Strategic tierMajor Media/Agency PartnerTypeChannel Partner/ Reseller/ Distributor
Description

CMI is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.

Strategic tierMajor Media/Agency PartnerTypeChannel Partner/ Reseller/ Distributor
Description

Klick Health is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.

Strategic tierMajor Media/Agency PartnerTypeChannel Partner/ Reseller/ Distributor
Description

DeepIntent is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.

Strategic tierMajor Media/Agency PartnerTypeChannel Partner/ Reseller/ Distributor
Description

Telium is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aktana provides AI-driven HCP engagement and omnichannel orchestration for life sciences, directly overlapping with ODAIA Field and Marketing Intelligence across dynamic call planning, next-best-action, and campaign sequencing for pharma commercial teams.

TypeBroad incumbent
Description

Veeva is the dominant pharma CRM and commercial operations platform (Veeva CRM, MyInsights, Vault) that ODAIA integrates with. It is a broad incumbent in life sciences commercial software and a key channel partner that could also embed competing AI features natively.

TypeBroad incumbent
Description

IQVIA combines pharmaceutical data, analytics, and commercial services (formerly IMS Health) used by the same biopharma commercial buyers that ODAIA targets. It is a broad incumbent with overlapping HCP targeting, engagement, and attribution capabilities.

TypeDirect peer
Description

OptimizeRx is a pharma HCP engagement and messaging platform that delivers targeted, real-time content to physicians, directly comparable to ODAIA's Marketing Intelligence omnichannel and Rx-attribution use case for life sciences commercial teams.

5ZS Associates
TypeBroad incumbent
Description

ZS is a major consulting and AI/data analytics firm serving pharma commercial organizations with targeting, segmentation, and sales-force effectiveness solutions, overlapping with ODAIA's Customer Science and Brand Strategy Studio offerings.

TypeEmerging player
Description

Indegene provides commercial, medical, and digital solutions for life sciences, including AI-driven HCP engagement and omnichannel capabilities that overlap with ODAIA's pharma commercial platform, particularly in brand strategy and field execution.

TypeEmerging player
Description

Komodo Health offers a healthcare data and analytics platform that powers patient- and HCP-level insights for life sciences, comparable to the underlying data and analytics layer ODAIA uses for HCP PowerScore and Rx-based attribution.

TypeBroad incumbent
Description

Salesforce is a flagship CRM integration partner for ODAIA and a broad incumbent in life sciences cloud software. Its Life Sciences Cloud and Einstein AI capabilities directly overlap with ODAIA's customer engagement and analytics use cases.

TypeEmerging player
Description

Definitive Healthcare provides commercial intelligence, HCP, and healthcare data analytics used by life sciences companies for targeting and engagement, with partial overlap to ODAIA's HCP and segmentation intelligence offerings.

TypeEmerging player
Description

WhizAI is a GenAI analytics platform purpose-built for life sciences commercial and medical teams, directly comparable to ODAIA's GenAI-powered Insights Engine and Brand Strategy Studio for pharma commercial users.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ODAIA

Pharmaceutical Commercial Intelligence Softwareodaia.ai

ODAIA is a Toronto-based AI software company that builds MAPTUAL, a vertical AI platform for pharmaceutical and biopharma commercial teams, delivering predictive HCP targeting, GenAI pre-call insights, omnichannel campaign orchestration, and Rx-based attribution to sales reps, marketers, and brand leaders.

What ODAIA does

ODAIA Intelligence Inc. is a Toronto-based, venture-backed AI software company founded in 2018 that builds MAPTUAL, a vertical AI platform purpose-built for pharmaceutical and biopharma commercial teams. The platform unifies data science, behavioral science, and AI across five proprietary engines — Value (HCP PowerScore), Curation (dynamic call lists), Insights (GenAI pre-call summaries), Sequencing (omnichannel orchestration), and Attribution (Rx-based campaign attribution) — to identify which healthcare professionals (HCPs) to engage, when, through which channel, and with what message. Underlying infrastructure is cloud-native and serverless on AWS (Lambda, Aurora, Fargate/Karpenter), with XGBoost, TensorFlow, a Parquet-based ML feature store, and bidirectional integrations into Veeva CRM (including a MyInsights tile) and Salesforce CRM, plus API connections to media and agency partners such as Publicis, CMI, Klick Health, DeepIntent, Telium, and Pulse Health.

ODAIA packages MAPTUAL into three primary product modules: ODAIA Field Intelligence for sales reps (with the ODAIA Field Coach add-on for sales managers), ODAIA Marketing Intelligence for marketing and brand teams, and the newly launched ODAIA Brand Strategy Studio for aligning brand planning with commercial execution. The company sells exclusively via direct enterprise SaaS subscriptions on quote-based, multi-year contracts, supplemented by implementation and integration services; pricing is not publicly disclosed and all engagement starts with a discovery call or demo. It reports 40+ pharma brands onboarded across customers including GSK, Novo Nordisk, Acadia Pharmaceuticals, Ardelyx, BeiGene, Daiichi Sankyo, and four of the top 15 global biopharmas.

ODAIA has raised roughly $43M in disclosed equity funding across pre-seed (Sep 2019), seed (Nov 2020), Series A (Feb 2022, $13.8M, Flint Capital lead), and a follow-on round (May 2023, $25M, Monograph Capital and Threshold co-lead), with secondary offices in Boston, MA and a remote-first operating model. Industry recognition includes being named a Sample Vendor in Gartner's 2023 Hype Cycle for Life Science Commercial Operations and the sole Major Contender and Star Performer in Everest Group's 2024 PEAK Matrix for Life Sciences Next-Generation Customer Engagement Platforms.

ODAIA firmographics

Firmographics
Name
ODAIA
Legal name
ODAIA Intelligence Inc.
Website
https://odaia.ai
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
101–250 employees
Short description
ODAIA is a Toronto-based AI software company that builds MAPTUAL, a vertical AI platform for pharmaceutical and biopharma commercial teams, delivering predictive HCP targeting, GenAI pre-call insights, omnichannel campaign orchestration, and Rx-based attribution to sales reps, marketers, and brand leaders.
Ownership category
akta.pro rank

Where ODAIA is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

ODAIA business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise SaaS subscriptions: Recurring software subscriptions for ODAIA Field and ODAIA Marketing Intelligence, sold to biopharma commercial teams (sales, marketing, brand) on a SaaS basis. Configurable deployments with multi-week setup, integrated with existing CRMs and media partners.
  2. Implementation, Integration & Onboarding Services: Professional services for configuration, integration with agency/media partners, and TPAs (third-party data) setup to deploy MAPTUAL for new customer brands.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based enterprise SaaS — no public price list

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

ODAIA product offering

Product offering

Core offering

ODAIA sells MAPTUAL, an AI-powered Commercial Intelligence Platform built specifically for pharmaceutical companies. The platform unifies prescribing data, engagement signals, CRM records, and physician attributes to deliver real-time HCP prioritization, dynamic call planning, individualized omnichannel campaign orchestration, and Rx-based attribution for pharma sales, marketing, brand, and commercial operations teams.

Product overview

ODAIA's offering is a platform-plus-modules architecture centered on its cloud solution MAPTUAL. The MAPTUAL platform provides the shared AI foundation (Value, Curation, Insights, Sequencing, and Attribution engines) and ships to customers as three primary product modules: ODAIA Field Intelligence (for sales reps, including the ODAIA Field Coach add-on for sales managers), ODAIA Marketing Intelligence (for marketing and brand teams), and the newly launched ODAIA Brand Strategy Studio (for aligning brand planning with commercial execution). Solution layers (Targeting Intelligence, Engagement Intelligence, Omnichannel Marketing, and Opportunity Analysis) and a CRM-embedded ODAIA Insights view for Veeva extend the platform across the pharma commercial workflow.

Differentiator

Problem solved

Functional benefit

Brands

  • MAPTUAL: ODAIA's cloud-based AI platform integrating data science, behavioral science, and AI for commercial pharma teams; the trademarked name is referenced alongside the ODAIA name in copyright notices and product descriptions.
  • Marketing Intelligence
  • Field Intelligence (ODAIA Field)
  • Field Coach (ODAIA Field Coach)
  • Brand Strategy Studio

Products and services

  • ODAIA Field Intelligence ML-driven SaaS product for pharma sales reps that uses patented ML models to compute HCP PowerScores, generate dynamic call lists, surface pre-call insights, and prioritize the right physicians for engagement. Integrates with Veeva CRM via MyInsights.
  • ODAIA Marketing Intelligence AI SaaS product for pharma marketing and brand teams that orchestrates individualized HCP campaigns by analyzing prescribing data, engagement signals, CRM records, and physician attributes in real time, with Rx-based attribution and bidirectional API integrations with Veeva, Salesforce, Publicis, CMI, Klick Health, DeepIntent, Telium, and Pulse Health.
  • ODAIA Field Coach Performance intelligence add-on module for pharma sales managers that delivers real-time territory assessment, per-rep activity analysis against PowerScore-driven suggestions, personalized coaching insights, and continuous performance tracking.
  • ODAIA Brand Strategy Studio AI-native platform designed to align pharma sales, marketing, and analytics teams by automating strategic planning, simulating market impacts, and enabling continuous brand strategy refinement based on real-time data.
  • MAPTUAL Platform The cloud-based AI platform that powers all ODAIA products, composed of five engines: Value Engine (HCP PowerScore), Curation Engine (Dynamic Call Lists), Insights Engine (GenAI pre-call insights), Sequencing Engine (omnichannel campaign orchestration), and Attribution Engine (Rx-based attribution).
  • Opportunity Analysis One-time diagnostic analysis service that identifies overlooked or over-served HCPs, territories, and growth areas for a pharma commercial team, typically delivered as a precursor engagement before dynamic targeting deployment.

Quantifiable outcome

  • 40+ brands onboarded, $53B+ revenue supported, 7–14% average incremental Rx lift, +14% brand reach
  • +6 more outcomes

Companies that use ODAIA

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles3 records

ODAIA technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature10 records

ODAIA partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship technology / gtm partnership, leadership expansion; not a corporate partner, flagship crm integration, core crm integration and major media/agency partner.

  • Pulse Healthflagship technology / gtm partnershipStrategic or Co-development Partner · 14 January 2026ODAIA and Pulse Health announced a technology partnership at the JP Morgan Healthcare Conference in San Francisco on January 14, 2026, combining their AI-powered marketing platforms to help pharmaceutical brands personalize HCP engagement. A joint customer deployed over 600 campaigns using the integrated solution, with ODAIA recommending 86% of HCPs in the target universe; the first month of activation yielded 10% HCP-to-Rx conversion and a 25% prescription volume increase among converters.
  • Andrew Gunn (new senior hire)leadership expansion; not a corporate partnerOthers · 19 November 2025ODAIA announced the addition of senior pharma and AI leaders Andrew Gunn and Jacqueline Markle to accelerate growth and industry adoption. Andrew Gunn is a senior leader (named hire), not a corporate alliance, and is captured here only for completeness given the source framing.
  • Jacqueline Markle (new senior hire)leadership expansion; not a corporate partnerOthers · 19 November 2025ODAIA announced the addition of senior pharma and AI leaders Andrew Gunn and Jacqueline Markle to accelerate growth and industry adoption. Jacqueline Markle is a senior leader (named hire), not a corporate alliance, and is captured here only for completeness given the source framing.
  • Veeva (Veeva Systems / Veeva CRM)flagship crm integrationTechnology or IntegrationODAIA integrates with Veeva CRM (including Veeva MyInsights) via a GenAI solution that delivers real-time, predictive HCP insights inside the rep workflow. ODAIA Field's Veeva integration is showcased as a primary 'Seamless Integration with Your CRM' on the Field product page, and a Veeva CRM Integration Demo is one of three flagship demo videos.
  • Salesforce (Salesforce CRM)core crm integrationTechnology or IntegrationODAIA connects with Salesforce CRM in addition to Veeva, with bidirectional API integrations used to activate HCP engagement sequences.
  • Publicismajor media/agency partnerChannel Partner/ Reseller/ DistributorPublicis is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API, helping pharma customers activate HCP campaigns through Publicis' media assets.
  • CMI Media Groupmajor media/agency partnerChannel Partner/ Reseller/ DistributorCMI is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.
  • Klick Healthmajor media/agency partnerChannel Partner/ Reseller/ DistributorKlick Health is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.
  • DeepIntentmajor media/agency partnerChannel Partner/ Reseller/ DistributorDeepIntent is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.
  • Teliummajor media/agency partnerChannel Partner/ Reseller/ DistributorTelium is listed as a media/agency partner integrated with ODAIA Marketing Intelligence via bidirectional API for HCP campaign activation.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

ODAIA competitors and assessment

Company assessment

Direct peers

  • Aktana: Aktana provides AI-driven HCP engagement and omnichannel orchestration for life sciences, directly overlapping with ODAIA Field and Marketing Intelligence across dynamic call planning, next-best-action, and campaign sequencing for pharma commercial teams.
  • OptimizeRx: OptimizeRx is a pharma HCP engagement and messaging platform that delivers targeted, real-time content to physicians, directly comparable to ODAIA's Marketing Intelligence omnichannel and Rx-attribution use case for life sciences commercial teams.

Broad incumbents

  • Veeva Systems: Veeva is the dominant pharma CRM and commercial operations platform (Veeva CRM, MyInsights, Vault) that ODAIA integrates with. It is a broad incumbent in life sciences commercial software and a key channel partner that could also embed competing AI features natively.
  • IQVIA: IQVIA combines pharmaceutical data, analytics, and commercial services (formerly IMS Health) used by the same biopharma commercial buyers that ODAIA targets. It is a broad incumbent with overlapping HCP targeting, engagement, and attribution capabilities.
  • ZS Associates: ZS is a major consulting and AI/data analytics firm serving pharma commercial organizations with targeting, segmentation, and sales-force effectiveness solutions, overlapping with ODAIA's Customer Science and Brand Strategy Studio offerings.
  • Salesforce (Life Sciences Cloud): Salesforce is a flagship CRM integration partner for ODAIA and a broad incumbent in life sciences cloud software. Its Life Sciences Cloud and Einstein AI capabilities directly overlap with ODAIA's customer engagement and analytics use cases.

Emerging players

  • Indegene: Indegene provides commercial, medical, and digital solutions for life sciences, including AI-driven HCP engagement and omnichannel capabilities that overlap with ODAIA's pharma commercial platform, particularly in brand strategy and field execution.
  • Komodo Health: Komodo Health offers a healthcare data and analytics platform that powers patient- and HCP-level insights for life sciences, comparable to the underlying data and analytics layer ODAIA uses for HCP PowerScore and Rx-based attribution.
  • Definitive Healthcare: Definitive Healthcare provides commercial intelligence, HCP, and healthcare data analytics used by life sciences companies for targeting and engagement, with partial overlap to ODAIA's HCP and segmentation intelligence offerings.
  • WhizAI: WhizAI is a GenAI analytics platform purpose-built for life sciences commercial and medical teams, directly comparable to ODAIA's GenAI-powered Insights Engine and Brand Strategy Studio for pharma commercial users.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ODAIA social profiles

Digital presence

ODAIA compliance and trust

Trust signal

Compliance2 records

ODAIA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ODAIA leadership team

Management profile

Number of profiles

Profiles11 records

ODAIA funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ODAIA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ODAIA

What does ODAIA do?

ODAIA sells MAPTUAL, an AI-powered Commercial Intelligence Platform built specifically for pharmaceutical companies. The platform unifies prescribing data, engagement signals, CRM records, and physician attributes to deliver real-time HCP prioritization, dynamic call planning, individualized omnichannel campaign orchestration, and Rx-based attribution for pharma sales, marketing, brand, and commercial operations teams.

Is ODAIA a public or private company?

ODAIA is a private company. It is classified as venture growth investor backed and is currently operating.

When was ODAIA founded?

ODAIA was founded in 2018. It employs 101 to 250 people.

Where is ODAIA based?

ODAIA is headquartered in Toronto, Canada, in the North America region.

How does ODAIA make money?

Two revenue lines are on record. Enterprise SaaS subscriptions are the primary driver. The others are implementation, Integration & Onboarding Services.

Who are ODAIA's main competitors?

Direct peers on record are Aktana and OptimizeRx. Broad incumbents are Veeva Systems, IQVIA, ZS Associates and Salesforce (Life Sciences Cloud). Emerging players are Indegene, Komodo Health, Definitive Healthcare and WhizAI.

Does ODAIA have an API?

Yes. ODAIA integrates with media and agency partners through bidirectional APIs for campaign dispatch and results. Per the Marketing Intelligence FAQ, "ODAIA connects with Veeva and Salesforce CRM, and integrates with media and agency partners through bidirectional APIs." For teams using platforms without a native connector, outputs are also available via CSV. No public developer documentation URL, SDK language, or rate-limit/versioning details are disclosed.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup ResearcherODAIA Raises US$15 Million Series CODAIA raised US$15 million in Series C funding led by Monograph Capital, with Publicis Health Media as anchor. The company will use the capital to deepen enterprise customer relationships and expand its platform through PHM's integration.BetaKitOdaia raises $15-million Series C round, inks deal with US health agencyOdaia, a University of Toronto spinout, closed a $15-million Series C round led by Monograph Capital with Publicis Health Media as an exclusive US partner. The funding will advance its AI platform for pharmaceutical commercial intelligence. The company plans to integrate the platform into PHM's partner companies.Pulse 2.0ODAIA Raises $15 Million To Expand Predictive Intelligence For PharmaODAIA raised $15 million in Series C financing led by Monograph Capital, with PHM participating. The company will use the funds to expand its predictive commercial intelligence platform for pharma and signed PHM as its exclusive U.S. agency partner. The platform combines signals to predict patient journeys and identify missed prescription opportunities.The SaaS NewsODAIA Raises $15M Series CODAIA, a Boston-Toronto AI company for pharma commercial intelligence, closed a $15M Series C round led by Monograph Capital. The funds will expand services to existing enterprise accounts and develop its platform. The company was founded in 2018 by Philip Poulidis.FinSMEsOdaia Closes US$15M Series C FinancingOdaia, a Toronto-based AI company for pharma commercial intelligence, closed a US$15M Series C round led by Monograph Capital and anchored by PHM. The company will use the funds to grow within enterprise pharma accounts and continue innovating its platform, which is used by four of the top 15 global biopharma organizations.Dealroom.coODAIA lands $15M Series C, ties up with Publicis agency PHM | Dealroom NewsODAIA, an AI company for pharma commercial intelligence, closed a $15 million Series C led by Monograph Capital, with PHM as strategic investor. The funds will deepen enterprise pharma work and expand the platform, which serves over 40 brands including Novo Nordisk and GSK. The round marks a shift toward distribution through PHM's pharma clients.citybizODAIA Raises $15 Million Series C Led by Monograph Capital to Expand AI Platform for Pharmaceutical CompaniesODAIA raised $15 million in Series C financing led by Monograph Capital, with PHM participating. The funds will expand its AI platform for pharmaceutical commercial intelligence and support a U.S. partnership with PHM. The company aims to scale its predictive analytics across multiple brands and therapeutic areas.HIT ConsultantODAIA Raises $15M, Scaling Predictive Pharma Commercial Intelligence Across Enterprise PortfoliosODAIA raised $15M in Series C financing led by Monograph Capital and anchored by PHM, with participation from prior investors. The company also signed a commercial platform agreement naming PHM as its exclusive U.S. agency partner. The platform unifies prescribing telemetry, field sales, and digital engagement into a single HCP record.PR NewswirePHM and ODAIA Partner to Advance AI-Driven HCP Engagement in Life SciencesPHM announced a partnership and strategic investment in ODAIA, an AI company delivering predictive commercial intelligence for pharma. PHM will be ODAIA's exclusive U.S. agency partner, bringing the platform to pharmaceutical brands to coordinate digital media and field sales for healthcare professionals. The investment anchors ODAIA's Series C funding.